“Through many studies and systematic reviews, PBM has demonstrated efficacy in preventing the incidence and severity of OM in patients receiving radiation therapy for head and neck cancers. For a company like MuReva to [produce] a really rigorously engineered device that’s really simple to use and train a center on: that’s what’s needed for the field.”
“We saw a patient that was enrolled in the PBM trial who was very concerned of developing painful mouth sores from OM and did not because of the Mureva device. The patient was crying because of happiness, because he didn’t have any mouth sores or any pain. To me, that’s success.“
“The benefit to using Mureva PBM is significant in the reduction of oral mucositis for patients undergoing head and neck cancer therapy. They do better, they have less pain, less mucositis, and overall feel better.”
